نتایج جستجو برای: cov

تعداد نتایج: 34631  

2013
Ralph A Tripp

Middle East Respiratory Syndrome (MERS) is a severe respiratory illness first reported in Saudi Arabia that is caused by a coronavirus called MERS-CoV. This virus causes substantial fever, cough, and shortness of breath, and approximately half of the people afflicted have died. The MERS-CoV cases have occurred in or near the Arabian Peninsula, and to date no cases have been identified in the U....

2018
Maria L. Agostini Erica L. Andres Amy C. Sims Rachel L. Graham Timothy P. Sheahan Xiaotao Lu Everett Clinton Smith James Brett Case Joy Y. Feng Robert Jordan Adrian S. Ray Tomas Cihlar Dustin Siegel Richard L. Mackman Michael O. Clarke Ralph S. Baric Mark R. Denison

Emerging coronaviruses (CoVs) cause severe disease in humans, but no approved therapeutics are available. The CoV nsp14 exoribonuclease (ExoN) has complicated development of antiviral nucleosides due to its proofreading activity. We recently reported that the nucleoside analogue GS-5734 (remdesivir) potently inhibits human and zoonotic CoVs in vitro and in a severe acute respiratory syndrome co...

Journal: :FEBS letters 2009
Chih-Jung Kuo Hun-Ge Liu Yueh-Kuei Lo Churl-Min Seong Kee-In Lee Young-Sik Jung Po-Huang Liang

Picornaviruses (PV) and coronaviruses (CoV) are positive-stranded RNA viruses which infect millions of people worldwide each year, resulting in a wide range of clinical outcomes. As reported in this study, using high throughput screening against approximately 6800 small molecules, we have identified several novel inhibitors of SARS-CoV 3CL(pro) with IC(50) of low microM. Interestingly, one of t...

Journal: :Antimicrobial agents and chemotherapy 2014
Robert L LaFemina

Two coronaviruses causing severe respiratory disease and high mortality rates emerging within the past dozen years reinforces the need for clinically efficacious antivirals targeting coronaviruses. Alternative screening approaches for antivirals against the recently emergent Middle East respiratory syndrome coronavirus (MERS-CoV) may provide lead compounds to address this need. Two Antimicrobia...

Journal: :Antimicrobial agents and chemotherapy 2015
Qi Liu Shuai Xia Zhiwu Sun Qian Wang Lanying Du Lu Lu Shibo Jiang

As of 23 July 2014, 837 laboratory-confirmed cases of Middle East respiratory syndrome (MERS-CoV) infection, including 291 deaths, had been reported to the WHO (http://www.who.int /csr/disease/coronavirus_infections/en/), raising concerns about its pandemic potential and calling for the development of vaccines and therapeutics against MERS-CoV infection. We previously identified peptidic HIV-1 ...

Journal: :Scientific reports 2015
Yang Yang Fei Ye Na Zhu Wenling Wang Yao Deng Zhengdong Zhao Wenjie Tan

Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel and highly pathogenic human coronavirus and has quickly spread to other countries in the Middle East, Europe, North Africa and Asia since 2012. Previous studies have shown that MERS-CoV ORF4b antagonizes the early antiviral alpha/beta interferon (IFN-α/β) response, which may significantly contribute to MERS-CoV pathogenesis; how...

2011
Susanne Pfefferle Julia Schöpf Manfred Kögl Caroline C. Friedel Marcel A. Müller Javier Carbajo-Lozoya Thorsten Stellberger Ekatarina von Dall’Armi Petra Herzog Stefan Kallies Daniela Niemeyer Vanessa Ditt Thomas Kuri Roland Züst Ksenia Pumpor Rolf Hilgenfeld Frank Schwarz Ralf Zimmer Imke Steffen Friedemann Weber Volker Thiel Georg Herrler Heinz-Jürgen Thiel Christel Schwegmann-Weßels Stefan Pöhlmann Jürgen Haas Christian Drosten Albrecht von Brunn

Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to (Coronavirus) CoV epidemics. Neither vaccines nor therapeutics are available against human and animal CoVs. Knowledge of host cell proteins that ta...

2013
Ahmed Abd El Wahed Pranav Patel Doris Heidenreich Frank T. Hufert Manfred Weidmann

The emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in the eastern Mediterranean and imported cases to Europe has alerted public health authorities. Currently, detection of MERS-CoV in patient samples is done by real-time RT-PCR. Samples collected from suspected cases are sent to highly-equipped centralized laboratories for screening. A rapid point-of-care test is needed to...

Journal: :Journal of molecular biology 2007
Xiaoyu Xue Haitao Yang Wei Shen Qi Zhao Jun Li Kailin Yang Cheng Chen Yinghua Jin Mark Bartlam Zihe Rao

The viral proteases have proven to be the most selective and useful for removing the fusion tags in fusion protein expression systems. As a key enzyme in the viral life-cycle, the main protease (M(pro)) is most attractive for drug design targeting the SARS coronavirus (SARS-CoV), the etiological agent responsible for the outbreak of severe acute respiratory syndrome (SARS) in 2003. In this stud...

Journal: :The Journal of infectious diseases 2014
Ziad A Memish Jaffar A Al-Tawfiq Hatem Q Makhdoom Abdullah Assiri Raafat F Alhakeem Ali Albarrak Sarah Alsubaie Abdullah A Al-Rabeeah Waleed H Hajomar Raheela Hussain Ali M Kheyami Abdullah Almutairi Esam I Azhar Christian Drosten Simon J Watson Paul Kellam Matthew Cotten Alimuddin Zumla

BACKGROUND Analysis of clinical samples from patients with new viral infections is critical to confirm the diagnosis, to specify the viral load, and to sequence data necessary for characterizing the viral kinetics, transmission, and evolution. We analyzed samples from 112 patients infected with the recently discovered Middle East respiratory syndrome coronavirus (MERS-CoV). METHODS Respirator...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید